While drugmaker Novo Nordisk says that 88% of Ozempic users with commercial insurance pay $25 or less, that leaves many without adequate coverage, especially those in low-income or rural areas, with limited access
Discussing the Friday papers, Yale University School of Medicine Professor and JACC editor Harlan Krumholz said in a JACC interview, "I begin to think about the weight loss almost as a side effect, I mean these [drugs] are really promoting health." He added, "I was thinking mostly about cardiometabolic health but there may be many mechanisms by which [semaglutide] is making us healthier, and in some ways this is suggesting it's helping us to resist the adverse consequences of the pandemic." Krumholz nevertheless noted that further research into the impacts of semaglutide was required
Therefore, inhibiting the cytokines that induce inflammation could decrease inflammation and its associated effects in our bodies by targeting DPP-4
[I advise patients that] these scammers are not even a registered business and that they cannot sue them for anything should something go wrong
But across the four studies including ours that I'm aware of, we don't see this in the short term, and I say short term because this drug has only been around for a few years
